Institute of Cancer and Genomic Sciences Using fundamental research and the power of genomics to develop better therapies in cancer and other complex diseases.
News World leading cancer trials in Birmingham get £10 million boost Adults and children with cancer will continue to benefit from world-class clinical trials led by the University of Birmingham
QS World University Subject Rankings released for 2023 University of Birmingham rises 30 places to be joint 62nd in the world for Life Sciences and Medicine.
28 April 2023 Brain cells are starved of energy when autophagy malfunctions, new study finds Research has major implications for neurodegenerative disease treatments
19 April 2023 Drug combination could overcome tumour resistance for some children’s cancers Children with some tumours may benefit from receiving a combination of inhibitor drugs, according to interim results of research presented at a conference.
05 April 2023 Birmingham team recognised for showing that blood vessel leakiness can identify brain tumours. A multi-centre trial, led by Professor Andrew Peet, has shown measuring brain tumour blood supply in children can indicate tumours that may be more aggressive.
10 March 2023 Novel urine-based test for non-invasive detection of bladder cancer The urine-based molecular test can quickly and accurately detect bladder cancer and streamline diagnosis, reducing the need for invasive cystoscopies.
13 February 2023 Conundrum solved over HPV link with head and neck cancer International analysis has found that discordant results between two types of HPV test linked with worse outcomes for patients
10 February 2023 Scientists reveal the genetic code controlling the development of blood cells from stem cells New study uncovers the information encoded in our DNA required for the transcriptional control of blood cell development from embryonic stem cells